Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults

Clinical trial NCT00457509 · COMPLETED

Trial details

NCT number: NCT00457509
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pandemic Influenza Influenza A Virus Infection Orthomyxoviridae Infections

Start date: 2007-01-01
Primary completion: 2009-11-01
Enrollment: 251

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.